In this episode, Jeff Jacobovitz, AGG trial attorney, adjunct law professor at AU-WCL (Criminal Antitrust), and chair of the firm’s Antitrust group, continues conversations on former President Donald Trump’s election...more
In this episode, Jeff Jacobovitz, AGG trial attorney, adjunct law professor at AUWCL (Criminal Antitrust), and chair of the firm’s Antitrust group, covers several issues related to the ongoing litigation against former...more
In this episode, Jeff Jacobovitz, AGG trial attorney, adjunct law professor at AU-WCL (Criminal Antitrust), and chair of the firm’s Antitrust group, discusses the latest updates in the ongoing litigation against former...more
In this episode, Jeff Jacobovitz, AGG trial attorney, adjunct law professor at AU-WCL (Criminal Antitrust), and chair of the firm’s Antitrust group, discusses developments in the pending litigation against former President...more
In this episode, Jeff Jacobovitz, AGG trial attorney, adjunct law professor at AU-WCL (Criminal Antitrust), and chair of the firm’s Antitrust group, discusses the latest updates in the pending criminal and civil litigation...more
In this episode, Jeff Jacobovitz, AGG trial attorney and chair of the firm’s Antitrust group, examines the D.C. and Georgia indictments of former President Donald Trump on charges related to alleged attempts to overturn the...more
In this episode, Jeff Jacobovitz, AGG trial attorney and chair of the firm’s Antitrust group, examines the indictment of former President Donald Trump concerning the mishandling of records at Mar-a-Lago with Cynthia Alksne, a...more
In this episode, Jeff Jacobovitz, AGG trial attorney, chair of the firm’s Antitrust group, and former Federal Trade Commission attorney, will discuss the recent civil and criminal investigations and indictments for “no-poach...more
In this episode, Jeff Jacobovitz, AGG trial attorney and chair of the firm’s Antitrust group, tackles the New York indictment of former President Trump with Cynthia Alksne, a career federal prosecutor, MSNBC legal analyst,...more
4/19/2023
The Pitch newsletter is a monthly update of legal issues and news affecting or related to the music, film and television, fine arts, media, professional athletics, eSports, and gaming industries. The Pitch features a diverse...more
1/28/2022
/ Copyright ,
Cryptoassets ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Metaverse ,
Music Industry ,
Musical Sound Recordings ,
Name and Likeness ,
Nirvana ,
Prince ,
Quentin Tarantino ,
Right of Publicity ,
Student Athletes
The Department of Justice (“DOJ”) and the Federal Trade Commission ( “FTC”) have both taken recent activity, which indicates there will be close scrutiny and enforcement of the pharmaceutical industry. The DOJ announced on...more
Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more
AGG’s Government Investigations Team Insights provides periodic updates covering legal and regulatory topics.
In this edition, we discuss a recent Florida district court case involving prosecutorial misconduct resulting...more
8/30/2021
/ Antitrust Provisions ,
Attorney Misconduct ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Environmental Justice ,
Environmental Policies ,
Environmental Protection Agency (EPA) ,
Ethics Breach ,
Federal Trade Commission (FTC) ,
Government Investigations ,
Privileged Documents ,
Wage-Fixing
In October 2016, the Antitrust Division of the Department of Justice (“DOJ”) and the Federal Trade Commission (“FTC”) issued an eleven-page joint guidance document entitled “Antitrust Guidance for Human Resource...more
Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more
7/26/2021
/ Cybersecurity ,
Food and Drug Administration (FDA) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Home Health Care ,
Life Sciences ,
Medical Devices ,
Medicare ,
OPDP ,
Pharmaceutical Industry ,
Pharmacies ,
Popular ,
Prescription Drugs ,
State Privacy Laws
On July 9, 2021, President Biden issued an “Executive Order on Promoting Competition in the American Economy.” The Order focuses on antitrust issues and contains provisions directly affecting pharmaceutical companies and...more
On July 9, 2021, President Biden issued an “Executive Order on Promoting Competition in the American Economy.” The Order focuses on antitrust issues and contains provisions directly affecting labor and employment issues that...more
In May, Governor Brian Kemp signed House Bill 617, which goes into effect on July 1, 2021. In doing so, Georgia has joined several other states with “Name, Image, and Likeness” (“NIL”) laws that take effect on this date. The...more
On April 29, 2021, the Federal Trade Commission (“FTC”) announced a record $20 million settlement with Vivint, a Utah-based smart home security and monitoring company. This settlement represents the largest in FTC history for...more
Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more
The Department of Justice’s Antitrust Division (DOJ) has once again indicted health care individuals and a health care company for violations of Section 1 of the Sherman Act. On March 30, 2021, the DOJ indicted a Regional...more
The Department of Justice Antitrust Division (“DOJ”) has recently announced two indictments alleging criminal antitrust violations against employers involving wage negotiation and no-poach theories. The cases, which...more
The Department of Justice’s (DOJ) Antitrust Section recently filed a lawsuit to enjoin the partial acquisition between Geisinger Health (Geisinger) and Evangelical Community Hospital (Evangelical). Geisinger had agreed to...more
Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more
On June 10, 2020, the Attorneys General from forty-six states, the District of Columbia, and four United States territories filed a lawsuit against twenty-six drug manufacturers, accusing them of a long-standing antitrust...more